欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号SE/H/0315/001
药品名称Relestat
活性成分
    • epinastine 0.5 mg/ml
剂型Eye drops, solution
上市许可持有人Allergan Pharmaceuticals Ireland
参考成员国 - 产品名称Sweden (SE)
互认成员国 - 产品名称
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Hungary (HU)
    • Czechia (CZ)
      2764/07
    • Slovakia (SK)
      PURIVIST
    • Poland (PL)
    • Germany (DE)
    • Denmark (DK)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Relestat 0,5 mg/ml Augentropfen
许可日期2003/03/04
最近更新日期2024/06/12
药物ATC编码
    • S01GX10 epinastine
申请类型
  • TypeLevel1：New Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Full Dossier Article 4.8 Di 65/65
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase